Investigator-initiated trial (IIT) teams constantly strive to prove value to their companies. In today’s pharmaceutical environment, it is not enough to merely approve trials suited to company research objectives. Rather, teams must approve these trials and negotiate clinical trial agreements (CTAs) efficiently. Continue reading
Medical publications remain an important consideration for companies’ dedicated and non-dedicated medical affairs staff. Earlier this year, Cutting Edge Information conducted a study examining companies’ guiding medical publication strategies and their annual output patterns.
Figure 1 shows that the highest percentage of surveyed companywide, business unit and country-level teams ranked the following as extremely relevant publication goals: Continue reading
It’s no secret that our communication practices continually evolve to match our communication capabilities. Why write a letter when you can make a phone call? Or call when you can send an email or text message? Why not use any number of social channels to reach out to, not just people you know, but the companies that you support? Medical information teams must now take on the daunting task of meeting customers — both patients and physicians — where they operate, while still remaining compliant.
Many pharma companies’ medical information teams receive requests via a number of different channels, including telephone, email, social media and fax. Physicians may also submit inquiries through intermediaries such as sales reps and medical science liaisons (MSLs). While traditional channels — telephone and reps — remain prominent, digital channels are gaining traction. One interviewed call center manager noted, “I’d say that just as recently as 3 or 4 years ago, three-fourths of our medical inquiries came in on fax or letter or phone call. Now I’d say that over two-thirds come in by email.” Continue reading
The foresight necessary to produce clinical publications is similar to preparing for and running a marathon. Before the race begins — or before a product launches — a lot of hard work goes into ensuring that the final outcome matches the desired result. Runners may train for weeks, months or even years to prepare themselves for an upcoming competition. In similar fashion, dedicated publications teams spend a lot of time ensuring that products will receive ample clinical publications support both before and after product launch. Continue reading
Pharmaceutical companies medical information groups often use outsourced call centers to support their activities. As such, keeping close track of the performance of these vendors has grown in importance. Many medical information groups have a set list of performance indicators paired with internal goals that must be met to ensure a consistent experience for callers. Pharmaceutical call center audits, in their various forms, allow companies to monitor vendors with the same level of detail that they would be able to do for an in-house team. Continue reading
Lets face it, Google makes us smarter. Well…not really. But it certainly gives us a window into all kinds of information that used to be held only by professionals. The healthcare industry has certainly seen an uptick in customer knowledge over the last several years. Patients and healthcare providers alike can now use their search engines to do fairly deep dives into diseases state information and treatment options. This access has a big impact on pharmaceutical call center management teams. Patients and health care providers can answer many of the questions that they formerly asked of medical information groups with quick internet search. Medical information teams are also receiving additional, more complicated questions than in the past. Continue reading
Medical publications help companies to communicate clinical trial findings, provide internal marketing support and educate the scientific community. To optimize strategic medical publications management, dedicated teams should be selective so that manuscripts are sent to the right scientific journals. When selecting a journal, companies may consider its impact factor, readership profile and cost. Continue reading
When it comes to managing and nurturing thought leader relationships and specifically the process of identifying key opinion leaders, companies have several options. Many choose to outsource the identification process and contact KOLs once they’ve been identified by the third-party vendor. For larger and mid-sized companies that are looking to expand into new therapeutic areas or geographic regions, vendors provide an extremely valuable and effective service. Continue reading
Over the years, pharmaceutical companies’ digital marketing activities have enabled them to adopt a different approach to reaching patients, caregivers and physicians alike. Beyond direct-to-consumer television ads and email sends, many organizations have branched out to incorporate new channels within their existing marketing strategies. To be certain, companies have developed a number of innovative branded and unbranded pharma digital marketing solutions using a multitude of platforms. For example, companies have launched Facebook pages, Twitter accounts and YouTube channels geared toward specific audiences as a means to generate campaign awareness and promote consumer education. However, with the growth of the technological age and digital capabilities, correcting misinformation can be just as much of a challenge as disseminating company and product information. Continue reading
I play video games often in my free time and hold a particular love for the Portal series. At the end of the first game, there is a cute song that contains the line, “We do what we must because we can.” There aren’t many similarities I can find between pharma and the fictional Aperture Science company from the games (pending any news regarding armies of mantis men). But that particular line lies parallel to the situation in which many companies find themselves as the digital age continues to bloom. Medical publications transparency, in particular, is one area in which several companies are only beginning to actually do what they must. Continue reading